BHVN peer analysis
Biohaven (BHVN) against its competitors: price, today's move, 1-year return and market value side by side.
BHVN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABCL AbCellera | $11.06 | -9.86% | 106.34% | – |
| CLDX Celldex Therapeutics | $29.03 | -3.55% | 11.65% | $2.36B |
| IMCR Immunocore | $29.79 | -2.30% | -7.46% | – |
| IMNM Immunome | $19.81 | 8.79% | 23.97% | – |
| NTLA Intellia | $11.67 | -6.42% | -4.85% | $1.75B |
| PHVS Pharvaris | $33.50 | -0.09% | 50.63% | – |
| SION Sionna Therapeutics | $3.87 | -3.25% | -89.82% | – |
| VERA Vera Therapeutics | $30.26 | -2.32% | 1.99% | – |
| XERS Xeris Biopharma | $10.13 | -5.42% | 4.33% | $1.95B |
| ZBIO Zenas BioPharma | $27.67 | -2.54% | -7.40% | – |
| BHVN Biohaven | $15.14 | -1.78% | -12.91% | $2.33B |
- BHVN's peers: ABCL (AbCellera), CLDX (Celldex Therapeutics), IMCR (Immunocore), IMNM (Immunome), NTLA (Intellia), PHVS (Pharvaris), SION (Sionna Therapeutics), VERA (Vera Therapeutics).
Updated 2026-11-02 23:14 UTC